Pier Luigi Filosso, MD, associate professor of Thoracic Surgery, University of Torino, Italy, discusses future approaches to treating patients with neuroendocrine tumors (NETs) of lung origin.

The backbone treatment for these patients will be surgery, Filosso explains. However, there needs to be new targeted therapies for patients with aggressive disease in terms of lymph node metastasis.

It is known that patients with low- and intermediate-risk tumors may develop recurrence or distant metastasis. Therefore, a strict clinical treatment plan needs to be developed for this population, Filosso adds.

Videos

Pier Luigi Filosso, MD, associate professor of Thoracic Surgery, University of Torino, Italy, discusses future approaches to treating patients with neuroendocrine tumors of lung origin. 


Pier Luigi Filosso, MD

Articles

Dr. Filosso on Future of Treating Patients With Lung NETs